238 results match your criteria: "Divisions of Hospital Medicine[Affiliation]"
J Hosp Med
January 2025
Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
J Healthc Manag
January 2025
Division of Hospital Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, and Rocky Mountain Regional VA Medical Center, Aurora, Colorado.
Goal: To evaluate long-term outcomes of Better Together Physician Coaching, a digital life-coaching program to improve resident well-being.
Methods: We performed a secondary analysis of survey data from the pilot program implementation between January 2021 and June 2022. An intention-to-treat analysis was completed for baseline versus post-6 months and baseline versus post-12 months for all outcome measures.
Pediatr Res
January 2025
Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
Hosp Pediatr
January 2025
Department of Pediatrics, Division of Hospital Medicine, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.
Background And Objectives: Medical student clinical clerkship evaluations provide feedback for growth and contribute to the clerkship grade and the student's residency application. Their importance is expected to increase even more with the recent change of the US Medical Licensing Examination Step 1 to a pass/fail designation. Timely completion of medical student clerkship evaluations is a problem.
View Article and Find Full Text PDFMedEdPORTAL
December 2024
Assistant Professor, Division of Hospital Medicine, Department of Internal Medicine, University of Nebraska Medical Center.
Introduction: Teaching procedural skills is an essential part of health professions education, yet formal training is often lacking from traditional curricula.
Methods: A workshop on teaching procedural skills was developed as part of a clinician educator track at a large health professions university. Participants included medical residents and fellows (postgraduate years 2-6) from various training programs.
Acta Cardiol Sin
November 2024
Department of Internal Medicine, Min-Sheng General Hospital, Taoyuan; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
For the primary prevention of atherosclerotic cardiovascular disease (ASCVD), the recommended treatment target for each modifiable risk factor is as follows: reducing body weight by 5-10%; blood pressure < 130/80 mmHg (systolic pressure < 120 mmHg in high-risk individuals); low-density lipoprotein cholesterol (LDL-C) < 100 mg/dL in high-risk individuals, LDL-C < 115 mg/dL in moderate-risk individuals, LDL-C < 130 mg/dL in low-risk individuals, and LDL-C < 160 mg/dL in those with a minimal; complete and persistent abstinence from cigarette smoking; hemoglobin A1C < 7.0%; fulfilling recommended amounts of the six food groups according to the Taiwan food guide; and moderate-intensity physical activity 150 min/wk or vigorous physical activity 75 min/wk. For the primary prevention of ASCVD by pharmacological treatment in individuals with modifiable risk factors/clinical conditions, statins are the first-line therapy for reducing LDL-C levels; some specific anti-diabetic drugs proven to be effective in randomized controlled trials for the primary prevention of ASCVD are recommended in patients with type 2 diabetes mellitus; pharmacological treatment is recommended to assist in weight management for obese patients with a body mass index ≥ 30 kg/m (or 27 kg/m who also have at least one ASCVD risk factor or obesity-related comorbidity); an angiotensin-converting enzyme inhibitor, a glucagon-like peptide-1 receptor agonist, a sodium-dependent glucose cotransporter-2 inhibitor, and finerenone can be used in diabetic patients with chronic kidney disease for the primary prevention of ASCVD.
View Article and Find Full Text PDFJ Hosp Med
November 2024
Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
J Hosp Med
January 2025
Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
J Hosp Med
December 2024
Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Pharmacogenet Genomics
January 2025
Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Pharmacogenetics promises to optimize treatment-related outcomes by informing optimal drug selection and dosing based on an individual's genotype in conjunction with other important clinical factors. Despite significant evidence of genetic associations with drug response, pharmacogenetic testing has not been widely implemented into clinical practice. Among the barriers to broad implementation are limited guidance for how to successfully integrate testing into clinical workflows and limited data on outcomes with pharmacogenetic implementation in clinical practice.
View Article and Find Full Text PDFOpen Forum Infect Dis
October 2024
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
Background: An escape room is a cooperative game that has been adapted into medical education and major academic conferences.
Methods: We describe the design, development, and implementation of an educational ID-themed escape room activity entitled "Out-BREAK!" at an international conference, IDWeek 2023. An anonymous survey was conducted to collect demographic data, assess participant satisfaction with the escape room puzzles, and gauge participant interest in game-based learning.
Hosp Pediatr
November 2024
General Pediatrics, Stanford University School of Medicine, Palo Alto.
Background And Objectives: Children with medical complexity (CMC) experience increased risk of adverse events during and after hospitalization, and these risks are even greater for CMC whose caregiver has a preferred language other than English. Because many adverse events for CMC may be attributable to communication challenges, understanding caregiver and physician perspectives may help prevent adverse events.
Methods: We conducted semistructured interviews with Spanish-speaking caregivers of hospitalized CMC and their inpatient attending physicians.
J Hosp Med
October 2024
Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio, USA.
J Hosp Med
September 2024
Executive Leadership in Academic Medicine® (ELAM) Program, Philadelphia, Pennsylvania, USA.
Acta Cardiol Sin
September 2024
Department of Internal Medicine, Min-Sheng General Hospital, Taoyuan; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
J Hosp Med
September 2024
Department of Pediatrics, Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Background And Objective: The financial burden of bronchiolitis-related hospitalizations in the United States surpasses $700 million annually. Procalcitonin (PCT) has garnered recent interest in pediatrics and has demonstrated the potential to decrease antibiotic usage in other illnesses. This study assessed PCT utilization trends in bronchiolitis, hypothesizing an annual increase in PCT testing.
View Article and Find Full Text PDFObjective: Postoperative communication errors contribute to patient harm and excess costs. There are no existing standards for postoperative handoff to the acute care inpatient unit. We aimed to compare the experiences and preferences of pediatric hospitalists and surgeons about the content and timing of this handoff.
View Article and Find Full Text PDFJ Hosp Med
September 2024
Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
J Hosp Med
September 2024
Department of Pediatrics, Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.
JAMA
September 2024
Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
J Hosp Med
August 2024
Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
J Hosp Med
July 2024
Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
J Hosp Med
October 2024
Department of Medicine, University of California, San Francisco, San Francisco, Virginia, USA.
J Hosp Med
October 2024
Department of Medicine, University of California, San Francisco, San Francisco, California, USA.